Brief: Ocuphire Pharma reports Q2 results

Opus Genetics

12/08/2022 12:16

Aug 12 (Reuters) - Ocuphire Pharma Inc  OCUP.O :
    * OCUPHIRE PHARMA ANNOUNCES FINANCIAL RESULTS FOR THE SECOND
QUARTER 2022 AND PROVIDES CORPORATE UPDATE
    * AS OF JUNE 30, 2022, OCUPHIRE HAD CASH AND CASH
EQUIVALENTS OF
APPROXIMATELY $17.0 MILLION
    * CURRENT CASH ON HAND WILL BE SUFFICIENT TO FUND OPERATIONS
THROUGH Q3 OF 2023
    * QTRLY NET LOSS PER SHARE: BASIC AND DILUTED $0.25
    * Q2 EARNINGS PER SHARE VIEW $-0.33 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX920rht 
Further company coverage:  OCUP.O